Ovarian Endometrioid Adenocarcinoma Active Not Recruiting Phase 3 Trials for Docetaxel (DB01248)
| Indication | Status | Phase |
|---|---|---|
| DBCOND0028505 (Ovarian Endometrioid Adenocarcinoma) | Active Not Recruiting | 3 |
| clinicaltrials.gov Identifier | Title | Purpose | Drugs |
|---|---|---|---|
| NCT00565851 | Carboplatin, Paclitaxel and Gemcitabine Hydrochloride With or Without Bevacizumab After Surgery in Treating Patients With Recurrent Ovarian, Epithelial, Primary Peritoneal, or Fallopian Tube Cancer | Treatment |